The new treatment could hit the market as early as 2027.

A promising new drug could put an end to cumbersome CPAP machines and allow millions of Americans to breathe easy and sleep soundly. Researchers at the biopharm company Apnimed have been developing a ...

Snoring is more than just a nighttime nuisance—it can signal underlying health issues, including sleep apnea. Understanding ...

AD109 works by targeting neuromuscular dysfunction of upper airway muscles during sleep, representing a potential new ...

A new sleep apnea pill reduced symptoms by 44 per cent in trials, offering hope for patients struggling with uncomfortable ...

Sound Sleep Medical assists patients to determine whether sleep apnea might be behind their constant fatigue, loud snoring, and daytime drowsiness. Free ...

Having both OSA and insomnia makes treatment more complex. Learn why addressing both is critical for heart health and how CBTi can help you stick to CPAP.

New research shows GLP-1 drugs like Ozempic may reduce sleep apnea severity — here's what the latest science says ...

Obstructive sleep apnea is caused by a mechanical problem that blocks the airway. Central sleep apnea occurs when the brain fails to send necessary messages to muscles that control breathing. And ...

Sleep apnea affects approximately 1 out of 8 people worldwide, and people often remain in the dark about what’s going on.

AD109, an investigational once-daily oral combination of aroxybutynin and atomoxetine, significantly improved airway ...

Oura Health Oy, the popular smart ring maker seeking to go public this year, unveiled a significantly thinner and lighter new ...